These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31238606)

  • 1. [Multi-level analysis on factors affecting the adherence to early antithrombotic therapy among people with acute ischemic stroke].
    Bai X; Song YP; Lyu XR; Rao FY; Qin W; Huang XY; Li ZX; Liu BH; Jiang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):610-615. PubMed ID: 31238606
    [No Abstract]   [Full Text] [Related]  

  • 2. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey.
    Wang YL; Wu D; Nguyen-Huynh MN; Zhou Y; Wang CX; Zhao XQ; Liao XL; Liu LP; Wang YJ;
    Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):775-81. PubMed ID: 20456429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-level and hospital-level determinants of the quality of acute stroke care: a multilevel modeling approach.
    Reeves MJ; Gargano J; Maier KS; Broderick JP; Frankel M; LaBresh KA; Moomaw CJ; Schwamm L
    Stroke; 2010 Dec; 41(12):2924-31. PubMed ID: 20966407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy for ischaemic stroke patients with AF/RHD in West China daily practice.
    Wang D; Liu J; Hao Z; Liu M; Tan G; Jiang X; Tao W
    Neurol Res; 2015 Oct; 37(10):902-7. PubMed ID: 26178783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in Antihypertensive Prescribing After Stroke: Linked Data From the Australian Stroke Clinical Registry.
    Dalli LL; Kim J; Thrift AG; Andrew NE; Lannin NA; Anderson CS; Grimley R; Katzenellenbogen JM; Boyd J; Lindley RI; Pollack M; Jude M; Durairaj R; Shah D; Cadilhac DA; Kilkenny MF
    Stroke; 2019 Dec; 50(12):3592-3599. PubMed ID: 31648630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of atrial fibrillation and inadequate antithrombotic management on mortality in acute neurovascular syndrome.
    Saarinen JT; Rusanen H; Sillanpää N; Huhtala H; Numminen H; Elovaara I
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2256-64. PubMed ID: 25156784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke.
    Bliden KP; Raviv G; Tantry US; Chaudhary R; Cochran JW; Navarese EP; Brannan T; Vyas A; Gurbel PA
    J Thromb Thrombolysis; 2019 Feb; 47(2):192-199. PubMed ID: 30673942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
    Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
    Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous thrombolytic therapy for acute anterior ischemic stroke: Experience at the French Military Teaching Hospital in Toulon from 2003 to 2014.
    Sahuc-Rodrigues P; Sagui E; Wybrecht D; Veyrières JB; Gazzola S; Dagain A; Valance J; Alla P; Faivre A
    Rev Neurol (Paris); 2018 Mar; 174(3):125-136. PubMed ID: 29128152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antithrombotic medications among elderly ischemic stroke patients.
    Lichtman JH; Naert L; Allen NB; Watanabe E; Jones SB; Barry LC; Bravata DM; Goldstein LB
    Circ Cardiovasc Qual Outcomes; 2011 Jan; 4(1):30-8. PubMed ID: 21098780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
    Muengtaweepongsa S; Dharmasaroja P; Kummark U
    J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke.
    Myint PK; Hellkamp AS; Fonarow GC; Reeves MJ; Schwamm LH; Schulte PJ; Xian Y; Suter RE; Bhatt DL; Saver JL; Peterson ED; Smith EE
    Stroke; 2016 Aug; 47(8):2066-74. PubMed ID: 27435402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.
    Gill D; Cox T; Aravind A; Wilding P; Korompoki E; Veltkamp R; Kar A
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1539-43. PubMed ID: 27053029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior use of antithrombotic agents and neurological functional outcome at discharge in patients with ischemic stroke.
    Paciaroni M; Agnelli G; Caso V; Venti M; Alberti A; Milia P; Silvestrelli G; Biagini S
    J Thromb Haemost; 2006 Sep; 4(9):1957-61. PubMed ID: 16961603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Combined Antithrombotic, Statins and Anti-Hypertensive Drugs in Acute Ischemic Stroke.
    Poudel RS; Thapa L; Shrestha S; Khatiwada D; Upadhyay N; Bhandari TR; Shrestha A
    JNMA J Nepal Med Assoc; 2015; 53(197):5-11. PubMed ID: 26983040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.